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Atherosclerotic plaque volume
and composition in symptomatic carotid
arteries assessed with multidetector CT
angiography; relationship with severity
of stenosis and cardiovascular risk factors
Abstract The purpose of this study
was to examine the volume and the
composition of atherosclerotic plaque
in symptomatic carotid arteries and to
investigate the relationship between
these plaque features and the severity
of stenosis and the presence of car-
diovascular risk factors. One hundred
patients with cerebrovascular symp-
toms underwent CT angiography. We
measured plaque volume (PV) and the
relative contribution of plaque com-
ponents (calcifications, fibrous tissue,
and lipid) in the symptomatic artery.
The contribution of different compo-
nents was measured as the number of
voxels within defined ranges of HU
values (calcification >130 HU, fibrous
tissue 60–130 HU, lipid core <60
HU). Fifty-seven patients had athero-
sclerotic plaque in the symptomatic
carotid artery. The severity of stenosis
and PV were moderately correlated.
Age and smoking were independently
related to PV. Patients with hyper-
cholesterolemia had significantly less
lipid and more calcium in their
plaques than patients without hyper-
cholesterolemia. Other cardiovascular
risk factors were not significantly
related to PVor plaque composition.
Luminal stenosis of the carotid artery
partly reflects the amount of athero-
sclerotic carotid disease. Plaque vol-
ume and plaque composition are
associated with cardiovascular risk
factors.
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Introduction
The causes of cerebral ischemia are multiple, but the three
most common pathophysiological mechanisms are athero-
sclerotic large-vessel disease, intracranial small-vessel
disease, and cardiac embolism. The severity of stenosis
caused by atherosclerosis in the carotid bifurcation is an
important risk factor for (recurrent) stroke and is used to
decide which patients could benefit from carotid interven-
tion, such as endarterectomy or stent placement [1].
However, luminal stenosis as a parameter of carotid artery
disease does not necessarily reflect the amount of athero-
sclerosis. For example, most symptomatic patients have
only mildly stenotic lesions [2]. This demonstrates that
other plaque features play a role in an acute ischemic event.
Accumulation of atherosclerotic plaque in the carotid
artery may lead to positive remodelling in which the
artery enlarges to preserve the luminal area [3]. In
addition, a certain amount of atherosclerosis should be
present in the carotid bulb before it causes stenosis.
Consequently, plaque volume is usually underestimated
by the degree of stenosis. Rupture of an atherosclerotic
plaque, which leads to embolization of thrombus or
plaque material to the intracranial arteries, is considered
an important underlying event of cerebrovascular symp-
toms. It is current opinion that plaque vulnerability to
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Rotterdam, The Netherlandsrupture is related to the composition of the plaque [4].
Therefore, plaque volume (PV) and plaque composition
may be parameters that help in a better risk prediction and
selection of patients who could benefit from surgical or
endovascular intervention.
CT angiography has established itself as an accurate
modality to assess the presence of atherosclerotic disease
and to grade the severity of stenosis [5]. In addition,
multidetector CT angiography (MDCTA) has the ability to
identify and quantify different plaque components (lipid,
fibrous tissue, and calcifications) [6–9].
In this cross-sectional study, we analyzed PV and the
composition of atherosclerotic plaque in symptomatic
carotid arteries with MDCTA to investigate the relationship
between these plaque features and the severity of stenosis
and the presence of cardiovascular risk factors. We
hypothesized that (1) the severity of stenosis was not
closely related to PV and (2) cardiovascular risk factors
were more related to PV than to severity of stenosis.
Methods
Patients
We studied 100 consecutive patients with ischemic cere-
brovascular symptoms in the territory of a nonoccluded
carotid artery. The study was approved by the Institutional
Review Board; all patients gave written informed consent.
CT protocol and image reconstruction
CT of the carotid arteries was performed on a 16-slice
MDCT system (Siemens, Sensation 16, Erlangen, Ger-
many) with a standardized optimized contrast-enhanced
protocol (120 kVp, 180 mAs, collimation 16×0.75 mm,
table feed 12 mm/rotation, pitch 1) [10].
Image reconstructions were made with a 120-mm field
of view, a matrix size of 512×512, a slice thickness of
1.0 mm, an increment of 0.6 mm, and an intermediate
reconstruction algorithm.
Volume of plaque and its components
We measured plaque and plaque-component volumes with
a polymeasure plug-in [9] for the freely available software
package ImageJ (Rasband, National Institute of Mental
Health, Bethesda, MD, USA) (Fig. 1).
Thisplug-inmadeitpossibletodrawROIsovertheouter
vessel wallcontourinconsecutiveaxialMDCTAimagesand
to automatically calculate the total number of pixels and the
numberofpixels ofdifferent rangesof Hounsfieldunit (HU)
values within these ROI. Different ranges of HU values
represent different plaque components (Fig. 1).
The cut-off point between calcifications and fibrous
tissue was set at 130 HU. The cut-off point between fibrous
tissue and lipid was set at 60 HU as assessed in previous
studies [6]. We adjusted the cut-off point between
atherosclerotic plaque and lumen for each patient on the
basis of the full width–half maximum principle [mean
lumen attenuation plus mean fibrous tissue attenuation
(≈88 HU) divided by two]. The pixels around the lumen,
with a range between 130 HU and the adjusted cut-off
value, were considered to be fibrous tissue.
To assess the border between lumen and atherosclerotic
plaque, it was necessary to draw a second ROI in each
image. Normally, the lumen area was then automatically
differentiated from atherosclerotic plaque on the basis of
the adjusted cut-off value. But in those plaques in which
calcifications bordered the lumen and the two structures
merged with each other, lumen area and calcifications had
to be separated by manual drawing.
The volume of the atherosclerotic plaque and its
components was calculated by multiplying the calculated
number of pixels, the pixel size, and the increment. The
proportion of plaque components was calculated as the
ratio of volume of the component to the total plaque
volume multiplied by 100. The length of the plaque was
calculated by multiplying the number of slices that
contained plaque by the increment (0.6 mm). Two
observers (S.R, T.T.d.W.), who were blinded to other
clinical information, performed the volume measurements
in consensus.
In a previous study, we evaluated the reproducibility of
the volume measurements in 56 symptomatic carotid
arteries. The averaged interclass correlation coefficient
was 0.88 for PV, 0.97 for percent calcification, 0.90 for
percent fibrous tissue, and 0.76 for percent lipid tissue [9].
Severity of stenosis
One observer (C.d.M.) measured the severity of stenosis
according to the NASCETcriteria on MPR images parallel
Fig. 1 Semi-automatic assessment of plaque component areas in
MDCT images. Axial MDCT image of an atherosclerotic carotid
plaque; the region of interest is drawn on the outer vessel wall (a).
Ranges of Hounsfield unit (HU) values represent three different
plaque components: yellow lipid core (<60 HU), red fibrous tissue
(60–130 HU), and white calcification (>130 HU) (b)
2295to the central lumen line. If juxtaluminal calcifications were
present, the window setting was widened to prevent
overestimation of the luminal stenosis.
We divided the severity of stenosis into five categories
(0, 1–29, 30–49, 50–69, and 70–99%).
Cardiovascular risk factors
We obtained clinical measures and information on risk
factors and medication during the patient’s visit at the
outpatient clinic. Subjects were categorized as currently,
ever, or never smoking. Hypertension was defined as
systolic blood pressure over 140 and/or diastolic blood
pressure over 90 mmHg during two episodes of at least
15 min of continuous noninvasive blood-pressure measure-
ment and/or treatment with antihypertensive medication.
Blood pressure-lowering drugs comprised ACE inhibitors,
calcium-antagonists, beta-blockers, and diuretics.
Hypercholesterolemia was defined as fasting cholesterol
over 5.0 mmol/l and/or use of cholesterol-lowering drugs.
Diabetes was defined as fasting serum glucose levels over
7.9 mmol/l, nonfasting serum glucose levels over
11.0 mmol/l, or use of antidiabetic medication.
Information was collected on previous cardiovascular
events and conditions (myocardial infarction, atrial fibrilla-
tion, angina pectoris, chronic heart failure, coronary artery
bypass grafting) and previous cerebrovascular events.
Statistical analysis
Data are presented as mean ± SD. Spearman’s correlation
coefficients (Rs) were calculated to analyze the relations
between (1) severity of stenosis and PV, (2) the proportion
of plaque components and PV, and (3) age and PV.
Because the distribution of plaque volume and severity
of stenosis were skewed, we used logistic regression to
determine the associations between cardiovascular risk
factors and PVor stenosis. The highest quartile of volume
or stenosis was compared to the lower three quartiles.
Firstly, age and gender were entered into the model.
Secondly, all cardiovascular risk factors were added. To
analyze the association of cardiovascular risk factors with
plaque composition, we used linear regression, adjusting
for age, sex, PV, and all risk factors. Because the
distribution of the proportion of plaque components was
skewed, we made a natural log-transformation (ln). To
calculate the mean ln proportion of plaque components for
the presence of significant cardiovascular risk factors, we
used analysis of covariance (ANCOVA), adjusting for age,
sex, PV, and all other risk factors. Because severe
calcification may hamper the quantification of lipid [6],
we repeated the analyses in which the contribution of
plaque components was involved, after exclusion of
severely calcified plaques (defined as >20% calcifications).
SPSS 11.0 for Windows (SPSS, Chicago, IL, USA) was
used for data analysis.
Results
Baseline characteristics
The baseline clinical characteristics are presented in
Table 1. Fifty-seven of 100 patients had atherosclerotic
plaque in the symptomatic carotid artery. The length of the
57 symptomatic atherosclerotic plaques was 20.9±
13.5 mm (range 3.6–70.2 mm). PVof the 57 atherosclerotic
plaques was 773±685 mm
3. Fibrous tissue and lipid were
present in all plaques. Calcifications were present in 54 of
the 57 plaques. The contribution of the lipid, fibrous, and
calcified plaque components was 18±12, 68±14, and 13±
11%, respectively. Thirty-five of the 54 patients (65%) with
minor stroke, 9 of the 19 patients (47%) with transient
ischemic attack (TIA), and 13 of the 27 patients (48%) with
amaurosis fugax (AF) had atherosclerotic plaque in their
symptomatic artery. The PV in patients with minor stroke
(884±627 mm
3) was larger than the PV in patients with
TIA (783±957 mm
3; P=0.19) and the PV in patients with
AF (469±573 mm
3; P<0.01) The contribution of calcifica-
tions was larger in minor stroke patients than in AF patients
(15±12% versus 9±6; P<0.05).
Plaque volume and severity of stenosis
Table 2 shows the volume ofthe plaque and the contribution
oftheplaquecomponentsforthedifferentgradesofstenosis.
In 20 out of 61 patients with a stenosis grade of 0%,
atherosclerotic plaque was present (PV=411±472 mm
3). In
18 of the 20 patients with a stenosis grade of 1–29%, plaque
Table 1 Demographic and clinical characteristics in patients with
cerebrovascular symptoms (n=100)
Characteristic Value
Age (years; mean±SD) 61±15
Male sex (%) 61
Symptoms
Amaurosis fugax, retinal infarct (%) 27
Transient ischemic attack (%) 19
Ischemic stroke (%) 54
Hypertension (%) 70
Hypercholesterolemia (%) 73
Diabetes Mellitus (%) 11
Smoking: current or past (%) 53
Previous cardiac disease (%) 18
Previous cerebrovascular disease (%) 24
2296was present with a PV of 543±464 mm
3. The correlation
between PVand severity of stenosis in the group of patients
who had an atherosclerotic plaque (n=57) was moderate
with an Rs of 0.66 (P<0.0001) (Figs. 2 and 3).
Plaque volume and plaque composition
Figure 4 shows the relationship between the contribution of
calcium, fibrous tissue, and lipid, and total PV in the 57
patients with atherosclerotic plaque. With increasing PV,
the contribution of fibrous tissue decreased (Rs=-0.83,
P<0.001) and the contribution of lipid increased (Rs=0.62,
P<0.001). With an increase in PV, the contribution of
calcium increased slightly (Rs=0.42, P=0.001). After
exclusion of severely calcified plaques, we still revealed
an increase in the contribution of lipid with increasing PV
(Rs=0.64, P=0.001).
Risk factors
There was a moderate relationship between age and PV for
both men and women (Rs=0.49, P=0.001 and Rs=0.48,
P<0.001, respectively). Table 3 shows the age and gender-
adjusted odds ratios (ORs) and 95% confidence intervals
(95% CI) and the multivariable adjusted ORs and 95% CIs
for associations between cardiovascular risk factors and (1)
atherosclerotic carotid PV and (2) severity of stenosis
(upper quartile versus lower three quartiles). Smoking was
independently related to PV (OR 4.9, 95% CI 1.2–19.3)
and to severity of stenosis (OR 4.6, 95% CI 1.2–18.1).
Subsequently, we analyzed the association between
plaque composition and cardiovascular risk factors. Pa-
tients with hypercholesterolemia had a significantly higher
contribution of calcium and a significantly lower contribu-
tion of lipid in the atherosclerotic plaque. The mean
proportion of calcium in the plaque of patients with and
without hypercholesterolemia was 9.9 and 2.0%, respec-
tively. The ln mean difference was 1.61 (95% CI 0.70–
2.53). The mean proportion of lipid in the plaque of
patients with and without hypercholesterolemia was 12.2
and 26.0%, respectively. The ln mean difference was -0.76
(95% CI -1.14 to -0.38). After exclusion of severely
calcified plaques, patients with hypercholesterolemia again
showed a significantly lower contribution of lipid in the
atherosclerotic plaque than patients without hypercholes-
terolemia (2.2 and 20.2%, respectively).
Discussion
In this study, we quantified and characterized athero-
sclerotic carotid plaque with MDCTA and examined
whether the relation between PV and the severity of
luminal stenosis was strong. A moderate association
between the severity of luminal stenosis and PV was
described in the present study. Smoking was associated
with both PVand severity of stenosis. Our hypothesis that
cardiovascular risk factors were more strongly associated
with PV than severity of stenosis was not supported in this
study. We demonstrated that an increasing PVis associated
with a change in plaque composition: the proportion of
calcium and lipid increases and the proportion of fibrous
tissue decreases. Finally, hypercholesterolemia was inde-
pendently related to plaque composition.
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Fig. 2 Scatter plots showing the relation between severity of
luminal stenosis (%) and total plaque volume (PV; mm
3)i n5 7
patients
Table 2 Severity of stenosis, number of patients with a certain degree of stenosis, number of patients with atherosclerotic plaque, and
plaque volume (PV) characteristics in the patients with atherosclerotic plaque
Stenosis (%) Number Number (PV>0) PV (mm
3) Calcium (%) Lipid (%) Fibrous (%)
0 61 20 411±472 10±8 13±11 76±9
1-29 20 18 543±464 13±13 16±9 70±12
30-49 6 6 930±367 14±10 23±13 63±14
50-69 5 5 1,734±675 24±13 26±8 50±7
70-99 8 8 1,480±708 14±11 30±13 55±17
Total 100 57 773±685 13±11 18±12 68±14
Values are numbers or means and standard deviations
2297Plaque volume and stenosis
There are several reasons why severity of stenosis is not a
good reflection of the amount of atherosclerotic disease.
Firstly, extensive atherosclerotic disease can be present
without stenosis of the lumen, and vice versa, stenosis can
be caused by a focal accumulation of a small amount of
atherosclerotic plaque (Fig. 3). Secondly, the configuration
of a normal carotid bulbus and bifurcation allows the
accumulation of extensive atherosclerotic plaque before a
luminal stenosis becomes visible on angiography. Thirdly,
vessel remodelling plays an additional role since the
discrepancy between the atherosclerotic plaque load and
angiographic appearance of the lumen is also present in
other vessel beds. A recent MRI study showed that luminal
stenosis provides an incomplete picture of atherosclerotic
progression and regression and that expansive remodelling
occurs specifically in the earlier stage of atherosclerosis
development in carotid arteries [11].
It is well known that atherosclerosis with low-grade
stenosis in the carotid bifurcation may result in cerebro-
vascular events [12]. In the present study, a relatively large
proportion of the patients with cerebrovascular symptoms
had atherosclerotic plaque with no luminal narrowing
measured according to the NASCETcriteria. Since PV is a
better descriptor of the severity of atherosclerotic disease
than degree of stenosis, and CT and MRI now allow the
quantification of atherosclerotic plaque, we advocate
evaluating the role of PV as an additional parameter in
the assessment of stroke risk and ultimately in treatment
decision-making.
Plaque volume and composition
The composition of the atherosclerotic plaque changes
during the progression of atherosclerotic disease, and this
plays an important role in the development of a vulnerable
plaque. Until now, most data on the temporal change in the
composition of the atherosclerotic plaque have been based
on cross-sectional studies in which vessel specimens
obtained during autopsy or operation (carotid endarterec-
tomy) were evaluated. Atherosclerotic plaques were
classified based on their composition and that classification
was considered to reflect the temporal natural history of
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Fig. 4 Scatter plot demonstrates the relation between the contribu-
tion of the three different plaque components and total plaque
volume in 57 patients. The gray line represents the contribution of
lipid, the dotted line represents the contribution of fibrous tissue, and
the solid black line represents the contribution of calcifications to
the total plaque volume
Fig. 3 CTangiograms of the carotid bifurcation with lesion. Sagittal
(a, d) and axial (b, c, e, f) images of atherosclerotic plaques in the
carotid bifurcation. The left panels show an extensive calcified
atherosclerotic plaque [plaque volume (PV)=1,318 mm
3] without
severe stenosis (20%). The right panels reveal a focal lesion at the
origin of the internal carotid artery with a moderate amount of
atherosclerosis (PV=169 mm
3) but severe stenosis (73%)
2298atherosclerotic disease [13]. Such studies have provided
tremendous information on the process of atherosclerotic
disease and the occurrence of clinical events. However,
much more can be expected from serial evaluation of an
atherosclerotic plaque with clinical imaging tools because
this will truly provide insight into the natural history of
atherosclerotic plaque and into the causal association of
changes in plaque composition and clinical events. With
regard to the natural history, the present cross-sectional
imaging study shows that plaque composition changes with
increasing PV. According to the AHA criteria, which
describe advanced atherosclerotic lesions in the carotid
artery as containing more lipid and more calcium, we found
an increase in the proportions of lipid and calcification with
increasingPV.Itwillbeofinterest toconfirm thesetemporal
changes in PVand composition with serial MDCTA.
Plaque volume and cardiovascular risk factors
The relation between cardiovascular risk factors and the
severity of atherosclerotic disease is difficult to evaluate,
and most studies have correlated cardiovascular risk factors
with indirect instead of direct measures of atherosclerotic
plaque burden [14]. Several large population-based studies
have demonstrated independent associations between car-
diovascular risk factors such as smoking, hypertension,
hypercholesterolemia, and diabetes and ultrasound (US)-
measured intima-media thickness (IMT) in the carotid
artery [15], severity of stenosis in the carotid artery [16],
carotid calcification [17], coronary stenosis [14], and
coronary calcification [14].
In our study, smoking was independently related to
severity of stenosis and PV. Other risk factors did not reach
a statistically significant association due to the limited
number of studied patients. Severity of stenosis as an
indirect parameter of atherosclerotic plaque burden has its
limitations. It reflects luminal narrowing and not the true
amount of atherosclerotic disease. Two recent studies
demonstrated that the relation between severity of stenosis
and cardiovascular risk factors was less strong than the
relation between intravascular US-assessed atherosclerotic
plaque burden and cardiovascular risk factors [18, 19].
Nicholls et al. concluded that different mechanisms
probably drive stenosis development and atheroma
accumulation [18].
Plaque composition and cardiovascular risk factors
Plaque composition is considered an important feature of
the so-called vulnerable plaque. Histological studies that
examined carotid endarterectomy specimens have shown
that the composition of the plaque is influenced by
cardiovascular risk factors: hypercholesterolemia and hy-
perfibrinogenemia were correlated with plaques rich in
foam cells [20, 21].
To our knowledge, this is the first study that describes the
relationship between the proportions of three different
carotid plaque components measured with MDCTA and
risk factors for atherosclerosis. We found that hypercholes-
terolemia was independently associated with the proportion
of lipid and calcium in the plaque. In comparison to the
histological studies, we found that patients with hypercho-
lesterolemia had a smaller proportion of lipid and a larger
proportion of calcium in their symptomatic plaques. This
might be explained by the large proportion of patients on
lipid-lowering drugs. IVUSstudies in coronary arteries have
revealed that statins reduce the lipid content of athero-
sclerotic plaques [22]. MRI studies on the carotid plaque
have shown that prolonged lipid-lowering drug therapy is
associated with markedly decreased lipid content [23].
Limitations
The first limitation of this study is the relatively small
number of patients on whom we performed our analysis.
We expect that analysis of a larger number of patients will
provide more evidence for the associations we investi-
Table 3 Relation between risk factors and atherosclerotic plaque volume or severity of stenosis in the symptomatic carotid artery (n=100)
Variable OR (95% CI) adjusted for age and gender OR (95% CI) adjusted for age, gender, and all risk factors
Plaque volume Severity of stenosis Plaque volume Severity of stenosis
Age (per 10 years) 2.3 (1.4–3.6) 2.0 (1.3–3.0) 3.1 (1.7–5.6) 2.9 (1.6–5.4)
Gender (male versus female) 2.0 (0.7–6.3) 2.0 (0.7–6.1) 1.7 (0.5–5.5) 1.9 (0.6–6.2)
Hypertension 1.7 (0.5–5.9) 1.7 (0.5–5.6) 2.3 (0.6–8.7) 1.7 (0.5–6.0)
Hypercholesterolemia 0.9 (0.3–3.0) 1.8 (0.5–5.9) 0.8 (0.2–3.0) 2.5 (0.6–10.7)
Diabetes mellitus 0.4 (0.1–2.3) 0.4 (0.1–2.3) 0.5 (0.1–4.0) 0.5 (0.1–4.1)
Smoking (ever) 3.9 (1.1–13.2) 4.4 (1.3–14.8) 4.9 (1.2–19.3) 4.6 (1.2–18.1)
Previous cardiac disease 1.8 (0.5–6.3) 0.9 (0.8–7.7) 2.5 (0.6–9.6) 0.8 (0.2–3.3)
Previous cerebrovascular disease 1.3 (0.4–4.2) 2.5 (0.8–7.7) 1.0 (0.3–3.6) 2.4 (0.7–8.4)
OR Odds ratio, CI confidence interval
2299gated. A second limitation is the cross-sectional design of
this study. Longitudinal studies are necessary to prove the
value of PV as a parameter for risk stratification. A third
limitation concerns the validation of CT to accurately
distinguish plaque components. Until now, CT and histol-
ogy have been compared side by side to define the range of
HU values for the different tissue types. Validation of these
cut-off points in a new prospective sample of patients is
required. A fourth limitation concerns the identification of
hemorrhage and thrombus. Wintermark et al. reported that
they could assess large intraplaque haemorrhage, defined
with the range of 72–177 Hounsfield units, with a kappa of
0.712 between CTA and histology [8]. However, we were
not able to confirm this in our own validation study and
have therefore restricted our analysis to calcifications,
fibrous tissue, and lipid core.
Despitetheselimitations,theconclusionofourstudymight
have some clinical implications. Firstly, the quantity of
atherosclerotic plaque, expressed as plaque volume, was
moderately associated with the severity of stenosis, which
impliesthatPVmightbeanimportantadditionalparameterin
the analysis of atherosclerosis in the carotid artery. Secondly,
PV and plaque composition are related to each other and to
risk factors for atherosclerosis. Noninvasive imaging of these
plaque parameters will increase the understanding of the
natural history of atherosclerotic disease in humans.
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